SEC 13F Intelligence

Brookmont Capital Management / JNJ

Brookmont Capital Management’s Johnson & Johnson Position

Does Brookmont Capital Management own Johnson & Johnson (JNJ)? Yes10.3K shares worth $3M (+1.41% of its 13F portfolio) as of Q1 2026, up from 10.0K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
10.3K
% of Portfolio
+1.41%
Quarters Held
30
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $3MQ2 ’19: $3MQ3 ’19: $3MQ4 ’19: $3MQ4 ’19Q1 ’20: $3MQ2 ’20: $2MQ3 ’20: $2MQ4 ’20: $2MQ4 ’20Q1 ’21: $3MQ2 ’21: $3MQ3 ’21: $2MQ4 ’21: $3MQ4 ’21Q1 ’22: $3MQ2 ’22: $3MQ3 ’22: $3MQ4 ’22: $3MQ4 ’22Q1 ’23: $2MQ2 ’23: $2MQ3 ’23: $2MQ4 ’23: $2MQ4 ’23Q1 ’24: $2MQ2 ’24: $2MQ3 ’24: $2MQ4 ’24: $2MQ4 ’24Q1 ’25: $2MQ2 ’25: $2MQ3 ’25: $2MQ4 ’25: $2MQ4 ’25Q1 ’26: $3Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202610.3K$3M+1.41%
Q4 202510.0K$2M+1.20%
Q3 202510.1K$2M+1.04%
Q2 202510.6K$2M+0.92%
Q1 202510.9K$2M+1.02%
Q4 202411.6K$2M+0.89%
Q3 202414.6K$2M+1.22%
Q2 202414.9K$2M+1.19%
Q1 202415.0K$2M+1.25%
Q4 202314.9K$2M+1.30%
Q3 202314.8K$2M+1.44%
Q2 202314.9K$2M+1.48%
Q1 202314.9K$2M+1.45%
Q4 202214.8K$3M+1.61%
Q3 202215.3K$3M+1.74%
Q2 202214.4K$3M+1.76%
Q1 202214.9K$3M+1.59%
Q4 202114.7K$3M+1.33%
Q3 202115.3K$2M+1.46%
Q2 202115.2K$3M+1.52%
Q1 202115.2K$3M+1.61%
Q4 202015.5K$2M+1.72%
Q3 202016.1K$2M+1.78%
Q2 202015.8K$2M+1.78%
Q1 202019.9K$3M+2.10%
Q4 201920.7K$3M+1.80%
Q3 201922.4K$3M+1.66%
Q2 201922.6K$3M+1.89%
Q1 201922.5K$3M+1.93%
Q4 201822.4K$3M+1.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Brookmont Capital Management’s full portfolio or all institutional holders of JNJ.